360

Development of a microplate-based, near-infrared fluorescent detection method for unbound bilirubin

Carl Peters BMG LABTECH, USA 07/2021
  • A method to directly detect free bilirubin is sought to better correlate with potential neurotoxicity
  • The use of red-shifted dyes is preferable due to the potential autofl uorescence of biological samples at shorter wavelengths
  • The utility of the CLARIOstar® for assay development and the PHERAstar® FSX as a high throughput platform is highlighted
     

Introduction

Bilirubin is a byproduct of hemoglobin turnover which is usually associated with albumin in plasma. However, in the case of hyperbilirubinemia, free bilirubin (Bf) can be present in the plasma at greatly elevated levels. Hyper-bilirubinemia is most problematic in children where it affects about 60 % of newborns and 80 % of premature babies. Bf passes through the blood-brain barrier where, if present in large amounts, it elicits neurotoxic effects and leads to seizures and brain damage.1


Fluoresprobe Sciences designed fluorescent assays to directly measure Bf, which is beneficial to determine the risk of encephelopathy. They have previously reported the use of fatty acid binding proteins (FABP) that are labeled with fluorescent markers2. Increased utility can now be achieved using a Bf sensitive FABP labeled with LICOR 700 DX and a Bf insensitive FABP labeled with LICOR 800 CW. The use of near infrared dyes is ideal for use with undiluted blood.


Improved throughput was achieved by the simultaneous dual emission detection of the PHERAstar FSX. Development of a suitable optic module was enabled by the scanning capabilities of a CLARIOstar microplate reader with a red-shifted photomultiplier tube (PMT).

 

Assay Principle

A ratiometric analysis system was employed that is based on previously characterized mutants of rIFABP. BL22P1B11 is bilirubin sensitive while SNRP1E2 is bilirubin insensitive. These binding proteins were labeled with the LICOR dyes 700DX and 800CW, respectively. The LICOR 700 DX signal is quenched in the presence of Bf while the LICOR 800 CW should be unchanged (Fig 1).

In the absence of free bilirubin both probes will have a high signal and the ratio below can be calculated.

As the levels of Bf increase it will quench the signal of BL22P1B11-700DX and the value of R will decrease.


Materials & Methods

  • BL22P1B11-700DX and SNRP1E2-800CW (Fluoresprobe Sciences)
  • 450 µM Human Serum Albumin (HSA) in 50 mM HEPES  buffer and bilirubin (BR)/450 µm HSA (0.5 molar ratio) in 50 mM HEPES buffer prepared by Fluoresprobe Sciences
  • PHERAstar FSX and CLARIOstar microplate reader (BMG LABTECH)

 

Spectral scanning
Free rIFABP fluorescently labeled probes were prepared at 1 µM in HEPES buffer and added to a black 96-well plate. Buffer controls were also added and both read on a CLARIOstar equipped with a red-shifted PMT using the following settings:

 

  BL22P1B11-700DX
  Excitation Scan Emission Scan
Excitation wavelength [nm] 547 -> 700 623
Excitation bandwidth [nm] 8 16
Emission wavelength [nm] 727 650 -> 700
Emission bandwidth [nm] 16 8
Gain 2023 1542

 

  SNRP1E2-800CW
  Excitation Scan Emission Scan
Excitation wavelength [nm] 633 -> 745 742
Excitation bandwidth [nm] 8 16
Emission wavelength [nm] 803 769 -> 840
Emission bandwidth [nm] 16 8
Gain 718 792

 

 

Bf ratiometric readings
BL22P1B11-700DX and SNRP1E2-800DX were combined and added to test wells. To this either 450 µM HSA or 0.5 BR / 450 µM HSA were added. Final concentrations were 1 µM for the fluorescent probes and 50 µM HSA. Control wells with either probe alone were included for calculation of signal to background. The plate was read on the CLARIOstar and PHERAstar FSX with the following settings:

 

  CLARIOstar
  Chromatic 1  Chromatic 2
Excitation 660-30
Dichroic 691.5
Emission 720-24 794-32
Gain 718 792

 

  PHERAstar FSX
Excitation 660
Emission A 795
Gain A  2349
Emission B 720
Gain B 1315

 

 

Results & Discussion

Our goal was to enable the use of PHERAstar FSX plate readers to detect this ratiometric Bf assay. First, the CLARIOstar was used to determine the spectral properties of the fluorophore. The results of our assessment are shown in figure 2. The Ex / Em scans of BL22PIB110-700DX clearly show maxima at 689 nm and 695 for Ex and Em, respectively. Furthermore, the Em maximum for SNRP1E2-800 CW can be seen at 800 nm. Although the Ex maximum for SNRP1E2-800CW is not observed in these scans the results are sufficient for our purpose as they allow us to compare the Ex spectra for BL22PIB110-700DX and SNSRP1E2-800CW.

Appropriate filters for the PHERAstar FSX optic module were selected based on the spectra shown in Fig. 2. An excitation wavelength suitable for both BL22PIB110-700DX and SNSRP1E2-800CW was chosen and near-peak emission wavelengths for each probe were selected.

 

The resulting optic module was then tested on samples that contained no bilirubin or sufficient excess bilirubin so that Bf should be observed (Table 1). As expected a strong fluorescent signal was observed at 720 nm for the BL22PIB110-700DX probe under zero bilirubin conditions which was reduced in the presence of bilirubin. In contrast, the signal for the SNSRP1E2-800CW was less affected by the presence of bilirubin probe. Thus the ratio of the signals also decreased when comparing zero bilirubin samples to those with Bf.

 

Table 1: Ratiometric Bf Assay

 

  PHERAstar FSXCLARIOstar
50mM Human Serum Albumin720 (avg.)143,530 RFU247,024
795 (avg.)71,681132,113
Ratio21.87
Human Serum Albumin and Bilirubi720 (avg.)110,356185,800
795 (avg.)61,804118,061
Ratio1.771.57

 

 

For comparison the results from the CLARIOstar are shown. The LVF monochromatorTM was set up to mimic the filters employed in the PHERAstar FSX optic module. The results in Table 1 show that comparable performance can be achieved between the CLARIOstar and PHERAstar FSX microplate readers.


Conclusion

This application note highlights the utility of the CLARIOstar as an assay and module development platform for the PHERAstar FSX. Using red-shifted PMTs on the CLARIOstar enabled scanning of NIR dyes and a suitable optic was developed. The performance of the module was tested and found suitable for the desired detection of Bf in samples. Importantly, the CLARIOstar also performed well in the same assay which helps to explain the ease of transition to the PHERAstar FSX from the CLARIOstar.


References

1. Wan ASL, Mat Daud S, Teh SH, Choo YM and Kutty FM (2016). Management of neonatal jaundice in primary care, Malays Fam Physician, 11: 16-19
2. Huber, AH, Zhu, B, Kwan, T, Kampf, JP, Hegyi, T and Kleinfeld, AM (2012). Fluorescence Sensor for the Quantifi cation of Unbound Bilirubin Concentrations, Clin Chem, 58: 869-876